期刊文献+

早产儿呼吸机治疗的围生期高危因素分析 被引量:3

High risk factors of premature mechanical ventilation in perinatal period
下载PDF
导出
摘要 目的:探讨早产儿需要持续正压通气(CPAP)和(或)气管插管呼吸机治疗的围生期高危因素。方法选取2009年11月至2013年6月出生、胎龄27~34周的403例早产儿进行研究。根据生后3 d内是否需要呼吸机支持治疗(>48 h)分为观察组154例与对照组249例。收集20项可能与早产儿是否需要呼吸机支持治疗相关的围生期因素,应用χ2检验和Logistic回归进行影响因素分析。结果在预测需要CPAP和(或)气管插管治疗的多变量模型中,有统计学意义的因素为胎龄<29周、出生体质量<1000 g、母亲妊娠期糖耐量异常、母亲妊娠期重度高血压综合征、胎膜早破>48 h、使用肺表面活性物质、频繁呼吸暂停、常规复苏后SaO2<85%、重度三凹征、早期喂养胃潴留(P<0.01或0.05)。结论综合分析胎龄、出生体质量低、使用肺表面活性物质、早产儿出生后早期出现频繁呼吸暂停、重度三凹征、常规复苏后SaO2低、早期喂养胃潴留、母亲妊娠期糖耐量异常、母亲妊娠期重度高血压疾病、胎膜早破这10项因素可以早期预测早产儿是否需要呼吸机支持治疗。 Objective To explore the high risk factors of premature mechanical ventilation in perinatal period. Methods A retrospective study of 403 preterm infants born from November 2009 to June 2013, gestational age 27-34 weeks was performed. Preterm infants were divided into observation group and control group,according to the application for mechanical ventilation during 3 days after birth. Twenty possible impact factors associated with mechanical ventilation support treatment in preterm infants were analyzed by Chi-squared test and Logistic regression. Results Ten significant factors in the multivariate model predicted the need for CPAP and (or)the treatment of tracheal intubation,which included gestational age 〈29 weeks,birth weight〈1 000 g,abnormal glucose tolerance during pregnancy,severe hypertension in pregnancy,premature rupture of membrane 〉2 days,pulmonary surfactant usage,frequent apnea,SaO2 after resuscitation 〈85%,severe three depressions and gastric residuals. Conclusions Comprehensive analysis of the above risk factors may be helpful for early prediction of ventilation support requirement in preterm infants.
出处 《新医学》 2014年第6期399-402,共4页 Journal of New Medicine
基金 2012年广东省第三批科技计划项目(粤科规划字[2012]145号)
关键词 辅助通气 早产儿 高危因素 Assisted ventilation Premature Risk factors
  • 相关文献

参考文献14

  • 1邵肖梅,叶鸿瑁,丘小汕.实用新生儿学.4版.北京:人民卫生出版社,201l:46,954-959.
  • 2Brennan G, Perlman JM. Neurologic complications of mechanical ventilation. New York: Springer, 2012: 685-690.
  • 3Morley CJ. Treatment of respiratory failure: mechanical ventilation. Milan: Springer, 2012: 497-508.
  • 4Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal re- spiratory distress syndrome in preterm infants-2013 up- date. Neonatology, 2013, 103 : 353-368.
  • 5Moriette G, Lescure S, E1 Ayoubi M, et al. Apnea of prematurity: what's new Arch Pediatr, 2010, 17: 186-190.
  • 6Poets CF. Apnea of prematurity : What can observational studies tell us about pathophysiology? Sleep Med, 2010, 11 : 701-707.
  • 7叶鸿瑁,虞人杰,黄醒华,王丹华,朱小瑜.新生儿复苏指南[J].中国新生儿科杂志,2011,26(4):224-228. 被引量:27
  • 8Chen M, Citil A, McCabe F, et al. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology, 2011, 99: 125-132.
  • 9Massaro GD, Radaeva S, Clerch LB, et al. Lung alveo- li: endogenous programmed destruction and regenera- tion. Am J Physiol Lung Cell Mol Physiol, 2002, 28: L305-L309.
  • 10Shlomai NO, Patole S. Nutrition in Preterm Infants with bronchopulmonary dysplasia. Netherlands: Springer, 2013 : 421-439.

二级参考文献12

共引文献120

同被引文献23

  • 1陈超.新生儿呼吸治疗技术的临床应用与规范[J].临床儿科杂志,2005,23(3):189-192. 被引量:19
  • 2刘霞,黄绮薇.持续呼吸道正压在新生儿呼吸支持治疗中的应用进展[J].国际儿科学杂志,2006,33(2):82-84. 被引量:5
  • 3Hsieh MH, Pai W, Tseng HI,Yang SN,Lu CC,Chen HL Par-enteral nutrition-associated cholestasis in premature babies : riskfactors and predictors. Pediatr Neonatol,2009,50 (5 ) : 202-207.
  • 4Lauriti G,Zani A,Aufieri R,Cananzi M,Chiesa PL,Eaton S,Pierro A. Incidence,prevention, and treatment of parenteral nu-trition -associated cholestasis and intestinal failure-associated liverdisease in infants and children: a systematic review. JPEN J Par-enter Enteral Nutr, 2014, 38 (1): 70-85.
  • 5Costa S, Maggio L, Sindico P, Cota F, De Carolis MP, Romag-noli C. Preterm small for gestational age infants are not at higherrisk for parenteral nutrition-associated cholestasis. J Pediatr.
  • 6Robinson DT,Ehrenkranz RA. Parenteral nutrition-associatedcholestasis in small for gestational age infants. J Pediatr,2008,152 (1) : 59-62.
  • 7Baserga MC,Sola A. Intrauterine growth restriction impacts toler-ance to total parenteral nutrition in extremely low birth weight in-fants. J Perinatol, 2004 , 24 ( 8) : 476-481.
  • 8Ozlii F, Yapicioglu PH, Mer K, Satar M, Narli N,SertdemirY. The effect of two different parenteral nutrition regimens on par-enteral nutrition-associated cholestasis. J Matem Fetal NeonatalMed, 2013, 26 (7) : 724-727.
  • 9Hsieh MH, Pai W, Tseng HI,Yang SN,Lu CC, Chen HL Par-enteral nutrition-associated cholestasis in premature babies : riskfactors and predictors. Pediatr Neonatol, 2009,50 (5) : 202-207.
  • 10Koseesirikul P, Chotinaruemol S, Ukarapol N. Incidence and riskfactors of parenteral nutrition-associated liver disease in newborninfants. Pediatr Int, 2012,54 (3) : 434-436.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部